相似文献
1
Resistant Hypertension in Chronic Kidney Disease: A Burden unto Itself.
Clin J Am Soc Nephrol. 2022 Oct;17(10):1436-1438. doi: 10.2215/CJN.09720822. Epub 2022 Sep 9.
2
Role of sodium restriction and diuretic therapy for "resistant" hypertension in chronic kidney disease.
Semin Nephrol. 2014;34(5):514-9. doi: 10.1016/j.semnephrol.2014.08.005.
3
Resistant Hypertension and Chronic Kidney Disease: a Dangerous Liaison.
Curr Hypertens Rep. 2016 Apr;18(5):36. doi: 10.1007/s11906-016-0641-x.
4
Recognition and Management of Resistant Hypertension.
Clin J Am Soc Nephrol. 2017 Mar 7;12(3):524-535. doi: 10.2215/CJN.06180616. Epub 2016 Nov 28.
5
Managing hypertension in patients with chronic kidney disease.
JAAPA. 2014 Sep;27(9):37-46. doi: 10.1097/01.JAA.0000453239.92473.41.
6
[Diuretic agent].
Nihon Rinsho. 2014 Aug;72(8):1472-6.
7
The double challenge of resistant hypertension and chronic kidney disease.
Lancet. 2015 Oct 17;386(10003):1588-98. doi: 10.1016/S0140-6736(15)00418-3.
8
Hypertension Management in Transition: From CKD to ESRD.
Adv Chronic Kidney Dis. 2016 Jul;23(4):255-61. doi: 10.1053/j.ackd.2016.02.002.
9
Resistant Hypertension in People With CKD: A Review.
Am J Kidney Dis. 2021 Jan;77(1):110-121. doi: 10.1053/j.ajkd.2020.04.017. Epub 2020 Jul 23.
10
Recent advances in the management of secondary hypertension: chronic kidney disease.
Hypertens Res. 2020 Sep;43(9):869-875. doi: 10.1038/s41440-020-0491-4. Epub 2020 Jun 17.
引用本文的文献
1
Long-term BPV is an Independent Risk Factor for Renal Prognosis in Hypertensive Patients - a Post-hoc Analysis of the SPRINT Study.
Int J Med Sci. 2025 Apr 22;22(10):2298-2307. doi: 10.7150/ijms.111843. eCollection 2025.
2
Hyperaldosteronism Screening and Findings From a Large Diverse Population With Resistant Hypertension Within an Integrated Health System.
Perm J. 2024 Mar 15;28(1):3-13. doi: 10.7812/TPP/23.096. Epub 2023 Nov 27.
本文引用的文献
1
Prevalence of Apparent Treatment-Resistant Hypertension in Chronic Kidney Disease in Two Large US Health Care Systems.
Clin J Am Soc Nephrol. 2022 Oct;17(10):1457-1466. doi: 10.2215/CJN.04110422. Epub 2022 Sep 9.
2
KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Blood Pressure in CKD.
Am J Kidney Dis. 2022 Mar;79(3):311-327. doi: 10.1053/j.ajkd.2021.09.013. Epub 2022 Jan 18.
3
Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease.
N Engl J Med. 2021 Dec 30;385(27):2507-2519. doi: 10.1056/NEJMoa2110730. Epub 2021 Nov 5.
4
Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans : A Retrospective Cohort Study.
Ann Intern Med. 2021 Mar;174(3):289-297. doi: 10.7326/M20-4873. Epub 2020 Dec 29.
5
Adverse Health Outcomes Associated With Refractory and Treatment-Resistant Hypertension in the Chronic Renal Insufficiency Cohort.
Hypertension. 2021 Jan;77(1):72-81. doi: 10.1161/HYPERTENSIONAHA.120.15064. Epub 2020 Nov 9.
6
Hypertension in CKD: Core Curriculum 2019.
Am J Kidney Dis. 2019 Jul;74(1):120-131. doi: 10.1053/j.ajkd.2018.12.044. Epub 2019 Mar 19.
7
Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.
Hypertension. 2018 Nov;72(5):e53-e90. doi: 10.1161/HYP.0000000000000084.
8
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Hypertension. 2018 Jun;71(6):e13-e115. doi: 10.1161/HYP.0000000000000065. Epub 2017 Nov 13.
9
Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.
Hypertension. 2016 Feb;67(2):387-96. doi: 10.1161/HYPERTENSIONAHA.115.06487. Epub 2015 Dec 28.
Zotero 插件